company background image
CLOV logo

Clover Health Investments NasdaqGS:CLOV Rapporto sulle azioni

Ultimo prezzo

US$3.37

Cap. di mercato

US$1.7b

7D

10.9%

1Y

224.0%

Aggiornato

22 Nov, 2024

Dati

Dati finanziari dell'azienda +

Clover Health Investments, Corp.

NasdaqGS:CLOV Rapporto sulle azioni

Cap. di mercato: US$1.7b

Clover Health Investments, Corp. Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Clover Health Investments
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$3.37
Massimo di 52 settimaneUS$4.71
Minimo di 52 settimaneUS$0.61
Beta2.04
1Variazione di 1 mese-10.85%
Variazione a 3 mesi0.90%
Variazione di 1 anno224.04%
3Variazione a 3 anni-37.71%
Variazione a 5 annin/a
Variazione dall'IPO-66.96%

Notizie e aggiornamenti recenti

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

Recent updates

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Rendimenti per gli azionisti

CLOVUS HealthcareUS Mercato
7D10.9%1.0%0.3%
1Y224.0%2.9%31.1%

Ritorno vs Industria: CLOV ha superato il US Healthcare che ha restituito 2.9 % nell'ultimo anno.

Rendimento vs Mercato: CLOV ha superato il mercato US che ha restituito 31.1 % nell'ultimo anno.

Volatilità dei prezzi

Is CLOV's price volatile compared to industry and market?
CLOV volatility
CLOV Average Weekly Movement13.0%
Healthcare Industry Average Movement7.1%
Market Average Movement6.2%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Prezzo delle azioni stabile: Il prezzo delle azioni di CLOV è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 13% ) di CLOV è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni US.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
n/a552Andrew Toywww.cloverhealth.com/en/

Clover Health Investments, Corp. fornisce piani di vantaggio medico negli Stati Uniti. Opera attraverso due segmenti: Assicurazione e Non assicurazione. Offre inoltre Clover Assistant, una piattaforma software basata su cloud che consente ai medici di rilevare, identificare e gestire più precocemente le malattie croniche e di accedere a informazioni personalizzate e basate sui dati per i pazienti in cura.

Clover Health Investments, Corp. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Clover Health Investments con la sua capitalizzazione di mercato?
CLOV statistiche fondamentali
Capitalizzazione di mercatoUS$1.68b
Guadagni(TTM)-US$95.94m
Ricavi(TTM)US$2.12b

0.8x

Rapporto P/S

-17.6x

Rapporto P/E

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
CLOV Conto economico (TTM)
RicaviUS$2.12b
Costo del fatturatoUS$1.78b
Profitto lordoUS$330.39m
Altre speseUS$426.33m
Guadagni-US$95.94m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)-0.19
Margine lordo15.62%
Margine di profitto netto-4.54%
Rapporto debito/patrimonio netto0%

Come si è comportato CLOV nel lungo periodo?

Vedi performance storica e confronto